Lotte Brückner

ORCID: 0000-0002-6155-2277
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • CRISPR and Genetic Engineering
  • Neuroblastoma Research and Treatments
  • Advanced Breast Cancer Therapies
  • Genetics, Bioinformatics, and Biomedical Research
  • Cancer therapeutics and mechanisms
  • Epigenetics and DNA Methylation
  • Science, Research, and Medicine
  • Cancer Genomics and Diagnostics
  • DNA Repair Mechanisms
  • PARP inhibition in cancer therapy
  • RNA Interference and Gene Delivery
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Genomics and Phylogenetic Studies
  • Spectroscopy and Chemometric Analyses
  • Cancer Diagnosis and Treatment
  • Medical Imaging and Pathology Studies
  • Computational Drug Discovery Methods
  • Spectroscopy Techniques in Biomedical and Chemical Research
  • Lung Cancer Treatments and Mutations
  • Single-cell and spatial transcriptomics
  • Multiple and Secondary Primary Cancers
  • Medical and Biological Ozone Research
  • Microtubule and mitosis dynamics
  • Renal cell carcinoma treatment
  • Pancreatic and Hepatic Oncology Research

Max Delbrück Center
2022-2024

Charité - Universitätsmedizin Berlin
2023-2024

Comprehensive Cancer Center Erlangen
2024

Humboldt-Universität zu Berlin
2023

Freie Universität Berlin
2023

Friedrich-Alexander-Universität Erlangen-Nürnberg
2023

Berlin Institute of Health at Charité - Universitätsmedizin Berlin
2022

University of York
2020

Heidelberg University
2017-2020

University Hospital Heidelberg
2020

Abstract Extrachromosomal DNAs (ecDNAs) are common in cancer, but many questions about their origin, structural dynamics and impact on intratumor heterogeneity still unresolved. Here we describe single-cell extrachromosomal circular DNA transcriptome sequencing (scEC&T-seq), a method for parallel of full-length mRNA from single cells. By applying scEC&T-seq to cancer cells, intercellular differences ecDNA content while investigating transcriptional impact. Oncogene-containing ecDNAs...

10.1038/s41588-023-01386-y article EN cc-by Nature Genetics 2023-05-01

Abstract Genomic instability arising from defective responses to DNA damage 1 or mitotic chromosomal imbalances 2 can lead the sequestration of in aberrant extranuclear structures called micronuclei (MN). Although MN are a hallmark ageing and diseases associated with genomic instability, catalogue genetic players that regulate generation remains be determined. Here we analyse 997 mouse mutant lines, revealing 145 genes whose loss significantly increases ( n = 71) decreases 74) formation,...

10.1038/s41586-023-07009-0 article EN cc-by Nature 2024-02-14

DNA amplifications in cancer do not only harbor oncogenes. We sought to determine whether passenger coamplifications could create collateral therapeutic vulnerabilities. Through an analysis of >3,000 genomes followed by the interrogation CRISPR-Cas9 loss-of-function screens across >700 cell lines, we determined that are accompanied distinct dependency profiles. In a proof-of-principle study, demonstrate coamplification bona fide gene DEAD-Box Helicase 1 (DDX1) creates increased on mTOR...

10.1158/2159-8290.cd-23-1189 article EN cc-by Cancer Discovery 2024-01-10

Circular extrachromosomal DNA (ecDNA) is a form of oncogene amplification found across cancer types and associated with poor outcome in patients. ecDNA can be structurally complex contain rearranged sequences derived from multiple chromosome locations. As the structure impact regulation may indicate mechanisms its formation, disentangling it at high resolution sequencing data essential. Even though methods have been developed to identify reconstruct genome sequencing, remains challenging...

10.1101/gr.279123.124 article EN cc-by-nc Genome Research 2024-08-07

We introduce an advanced and flexible spectral focusing coherent anti-Stokes Raman scattering (CARS) microspectroscopy scheme based on the independent control of pump, Stokes, probe frequencies offered by a pulse shaper. Adjusting instantaneous bandwidth 10 fs pulses in focus microscope to different linewidths assures high resolution signal intensities from CH-bond fingerprint region. Experimental results are confirmed simulations CARS generation process. By delaying probe, increased...

10.1364/josab.33.001482 article EN Journal of the Optical Society of America B 2016-06-17

Abstract Neuroblastoma is characterised by extensive inter- and intra-tumour genetic heterogeneity varying clinical outcomes. One possible driver for this are extrachromosomal DNAs (ecDNA), which segregate independently to the daughter cells during cell division can lead rapid amplification of oncogenes. While ecDNA-mediated oncogene has been shown be associated with poor prognosis in many cancer entities, effects ecDNA copy number on intermediate phenotypes still poorly understood. Here, we...

10.1101/2023.01.21.525014 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2023-01-21

Abstract Circular extrachromosomal DNA (ecDNA) is a form of oncogene amplification found across cancer types and associated with poor outcome in patients. EcDNA can be structurally complex contain rearranged sequences derived from multiple chromosome locations. As the structure ecDNA impact regulation may indicate mechanisms its formation, disentangling it at high resolution sequencing data essential. Even though methods have been developed to identify reconstruct genome sequencing, remains...

10.1101/2023.11.15.567169 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2023-11-17

Eslicarbazepine acetate (ESL) is a dibenzazepine anticonvulsant approved as adjunctive treatment for partial-onset epileptic seizures. Following first pass hydrolysis of ESL, S-licarbazepine (S-Lic) represents around 95% circulating active metabolites. S-Lic the main enantiomer responsible activity and this proposed to be through blockade voltage-gated Na+ channels (VGSCs). ESL both have voltage-dependent inhibitory effect on current in N1E-115 neuroblastoma cells expressing neuronal VGSC...

10.3389/fphar.2020.555047 article EN cc-by Frontiers in Pharmacology 2020-10-02

Abstract The small-molecule inhibitor of ataxia telangiectasia and Rad3-related protein (ATR), elimusertib, is currently being tested clinically in various cancer entities adults children. Its preclinical antitumor activity pediatric malignancies, however, largely unknown. We here assessed the elimusertib 38 cell lines 32 patient-derived xenograft (PDX) models derived from common solid tumor entities. Detailed vitro vivo molecular characterization treated enabled evaluation response...

10.1158/1535-7163.mct-23-0094 article EN cc-by-nc-nd Molecular Cancer Therapeutics 2023-12-29

ABSTRACT The chromosomal theory of inheritance has dominated human genetics, including cancer genetics. Genes on the same chromosome segregate together while genes different chromosomes assort independently, providing a fundamental tenet Mendelian inheritance. Extrachromosomal DNA (ecDNA) is frequent event in that drives oncogene amplification, dysregulated gene expression and intratumoral heterogeneity, through random segregation during cell division. Distinct ecDNA sequences, herein termed...

10.1101/2023.07.18.549597 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2023-07-19
Coming Soon ...